Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study

摘要

We aim to evaluate serum neurofilament light chain (sNfL), indicating neuroaxonal damage, as a biomarker at diagnosis in a large cohort of early multiple sclerosis (MS) patients.